Whole Genome Sequencing

About GeneDx Holdings

GeneDx Holdings Corp., operating as GeneDx, is a commercial-stage genomic diagnostics company that emerged from the combination of GeneDx and Sema4. The company's mission is to expand the use of genomic and clinical data to improve the diagnosis and management of disease globally. It leverages one of the world's largest clinical genomics databases and advanced AI/ML tools to enhance test interpretation and accelerate diagnostic yields. GeneDx is publicly traded on the Nasdaq under the ticker WGS and is strategically positioned to capitalize on the growing adoption of genetic testing in mainstream medicine.

Therapeutic Areas